Now that Thanksgiving is officially over, we are into the home stretch of the year with just December to go. For those of you following the biotech IPO market, there are in reality about two weeks left in the year as everything really closes down...
• Fiserv in talks with Australian banks
• Conjugon taps former Abbott Labs executive for board
• Johnson Controls works to standardize automotive products...
Madison, Wis. — After two days of demostrating Wisconsin's breakthroughs in biotechnology, the Wisconsin Life Sciences and Venture Conference closed last Wednesday with a discussion of what the state must do to attract business. Without capital, they said, the state will not be able to...
Wisconsin is pulling its weight in life-sciences research, as presenters showed at the recent Life Sciences and Venture Conference. But where were all the VCs?...
Angel investors and venture capitalists were treated to an exhibition of Wisconsin’s continually evolving technology culture at the Wisconsin Life Sciences and Venture Conference, held Tuesday and Wednesday at the Monona Terrace....
Wisconsin should hold on to its advantage in health and life-science research with $375 million for a UW-Madison research center and another $276 million spread between UW-Madison and Milwaukee, Governor Jim Doyle says. He also wants the Legislature to repeal regulatory hurdles that can get...
The answer to reversing the deterioration caused by acute diseases of the brain and heart may lie in stem-cell treatment, according to the ongoing research at the University of Wisconsin-Madison. Two experts spoke on Wednesday on their potential....
The managing director of WARF – holder of UW-Madison’s patents on stem-cell techniques – discusses California’s $3 billion stem-cell initiative and Wisconsin’s response, given its head start in the field....
Wisconsin recently saw the sudden death of another star. In this case, he was a world-renowned scientist for which Wisconsin was also not his birthplace. Unfortunately, few were around to sing his deserving praise....
Brand-new stem cells, free — State may fund manufacturers — Bone Care on Nasdaq — Modine’s army contract — Maintenance through instant messaging — Criticare revenue drops...